DSM-Firmenich, the group formed through the merger between Geneva-based Firmenich and Dutch group DSM, is taking a new step in its development with a secondary listing on the Swiss Stock Exchange.
Already listed in Amsterdam, the group is now joining the SPI, the broad Swiss market index, marking a symbolic and strategic return to a financial marketplace historically connected to its business activities.
In a segment broadcast on RTS La Matinale, Daniel Steck discussed the key implications of this decision.
A strategy focused on visibility and investor proximity
According to Daniel Steck, this dual listing primarily reflects the group’s intention to strengthen its visibility among Swiss investors:
“This clearly reflects the desire to return to a more natural stock exchange, given that DSM-Firmenich’s legal headquarters are located in Switzerland.”
Beyond the symbolic dimension, this decision could also enable the group to benefit from improved liquidity and stronger access to investors who are particularly familiar with the chemicals and life sciences industries.
A strategic sector in which Switzerland plays a central role
The global flavours and fragrances market remains highly concentrated, with only a handful of major international players.
Switzerland plays a key role in this industry through the presence of leading companies such as Givaudan, while DSM-Firmenich is now reinforcing its footprint on the Swiss market.
This listing further confirms the importance of Switzerland as a major hub for a high value-added sector combining innovation, research and industrial expertise.
Wealth solutions
Pension planning
Financing
Investment